A lifesaving cancer therapy may actually be causing new diseases in patients receiving the treatment.
The Food and Drug Administration on Tuesday said it was investigating reports of 19 cases of new cancer linked to CAR-T therapies, which are given to terminal blood cancer patients.
The treatment sees immune cells taken from the body and engineered to attack tumors before being infused back into the patient’s blood.
Experts say the breakthrough treatment has saved the lives of thousands of patients since it was approved in 2017.
But the way it is delivered may disrupt cell DNA and lead to other cancers, which is a small risk with all so-called gene therapies.
www.dailymail.co.uk/health/article-12805457/cancer-therapy-CAR-T-FDA-warning.html
Views: 173